Education
About Us
Working with TipRanks
Follow Us
Quantum-Si (QSI)
NASDAQ:QSI
QSI Stock Chart & Stats
$2.20
-$0.96(-27.61%)
At close: 4:00 PM EST
$2.20
-$0.96(-27.61%)
Day’s Range― - ―
52-Week Range$0.61 - $5.77
Previous CloseN/A
Volume35.47M
Average Volume (3M)17.87M
Market Cap
$445.49M
Enterprise Value$156.84M
Total Cash (Recent Filing)$214.21M
Total Debt (Recent Filing)$11.14M
Price to Earnings (P/E)―
Beta2.65
Next Earnings
Nov 05, 2025EPS Estimate
-0.13Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.16
Shares Outstanding182,557,700
10 Day Avg. Volume26,552,846
30 Day Avg. Volume17,873,619
Financial Highlights & Ratios
PEG Ratio-0.87
Price to Book (P/B)1.79
Price to Sales (P/S)126.43
P/FCF Ratio-4.19
Enterprise Value/Market Cap0.35
Enterprise Value/Revenue45.97
Enterprise Value/Gross Profit86.46
Enterprise Value/Ebitda-1.47
Forecast
1Y Price Target
$2.50Price Target Upside13.64% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
Bulls Say, Bears Say
Bulls Say
Market ExpansionContinued improvements to QSI's sequencing kits could help lead to the identification of a 'killer app' for protein sequencing and expand adoption levels for its technology.
PartnershipsThe company's partnership with Avantor is viewed as a tailwind to sales in the biopharma sector.
Product DevelopmentQSI's new kit improves sequencing coverage with the addition of glycine recognition, enhanced alanine and serine recognition, an enzyme designed to cut through the amino acid directly proceeding proline and new algorithms to benefit precision and mixture handling.
Bears Say
Financial PerformanceThe company's recent financial performance has been negatively affected by macroeconomic headwinds.
Revenue ChallengesManagement reported markedly lower revenue than the consensus expectation, attributing it partially to NIH funding challenges and a shift towards biopharmaceutical companies with longer sales cycles.
Quantum-Si News
QSI FAQ
What was Quantum-Si’s price range in the past 12 months?
Quantum-Si lowest stock price was $0.61 and its highest was $5.77 in the past 12 months.
What is Quantum-Si’s market cap?
Quantum-Si’s market cap is $445.49M.
When is Quantum-Si’s upcoming earnings report date?
Quantum-Si’s upcoming earnings report date is Nov 05, 2025 which is in 11 days.
How were Quantum-Si’s earnings last quarter?
Quantum-Si released its earnings results on Aug 05, 2025. The company reported -$0.16 earnings per share for the quarter, missing the consensus estimate of -$0.143 by -$0.017.
Is Quantum-Si overvalued?
According to Wall Street analysts Quantum-Si’s price is currently Undervalued.
Does Quantum-Si pay dividends?
Quantum-Si does not currently pay dividends.
What is Quantum-Si’s EPS estimate?
Quantum-Si’s EPS estimate is -0.13.
How many shares outstanding does Quantum-Si have?
Quantum-Si has 182,557,700 shares outstanding.
What happened to Quantum-Si’s price movement after its last earnings report?
Quantum-Si reported an EPS of -$0.16 in its last earnings report, missing expectations of -$0.143. Following the earnings report the stock price went down -4.861%.
Which hedge fund is a major shareholder of Quantum-Si?
Currently, no hedge funds are holding shares in QSI
Quantum-Si Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$2.50 (13.64% Upside)
$2.50 (13.64% Upside)
Blogger Sentiment
Neutral
QSI Sentiment 75%
Sector Average 68%
Sector Average 68%
Hedge Fund Trend
Decreased
By 752.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $159.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.2%
Last 30 Days ▲ 8.5%
Last 30 Days ▲ 8.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
177.77%
12-Months-Change
Fundamentals
Return on Equity
-46.87%
Trailing 12-Months
Asset Growth
-0.91%
Trailing 12-Months
Company Description
Quantum-Si
Quantum-Si incorporated, a life sciences company, develops a single molecule detection platform for sample preparation and sequencing. It offers a proprietary single molecule detection platform for use in semiconductor industry to field proteomics to enable next generation protein sequencing. The company was incorporated in 2013 is based in Guilford, Connecticut.
QSI Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed outlook. While there were significant advancements in product development and strategic initiatives to counteract capital sales challenges, revenue fell short of expectations due to NIH funding uncertainties. The company's strong cash position and innovation roadmap progress are positives, but the lack of financial guidance and increased operating expenses indicate ongoing challenges.View all QSI earnings summariesQSI Stock 12 Month Forecast
Average Price Target
$2.50
▲(13.64% Upside)
Technical Analysis
Ownership Overview
23.12% Insiders
7.46% Mutual Funds
11.88% Other Institutional Investors
45.84% Public Companies and
Individual Investors